What clinical signs indicate hypertrophic cardiomyopathy in an otherwise asymptomatic adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Clinical Signs of Hypertrophic Cardiomyopathy in Asymptomatic Adults

In an otherwise asymptomatic adult, the key clinical signs of HCM are an abnormal ECG (present in 75-95% of cases), a harsh crescendo-decrescendo systolic murmur that increases with Valsalva or standing, a prominent apical impulse, an abnormal carotid pulse, and a fourth heart sound 1, 2, 3.

Physical Examination Findings

The physical examination may reveal several characteristic signs, though approximately 23-50% of HCM patients may have a completely normal physical examination, particularly those without left ventricular outflow tract obstruction (LVOTO) 3, 4.

Cardiac Auscultation

  • Systolic murmur: Harsh crescendo-decrescendo quality, best heard between the apex and left sternal border
  • The murmur increases in intensity with maneuvers that decrease preload (Valsalva, standing from squatting position)
  • Fourth heart sound (S4) due to forceful atrial contraction against a stiff ventricle
  • Late systolic murmur of mitral regurgitation may be present, directed posteriorly 3

Cardiovascular Signs

  • Prominent or displaced apical point of maximal impulse (sustained and forceful)
  • Abnormal carotid pulse: Brisk upstroke with bifid quality (spike-and-dome pattern)
  • These findings are most evident in patients with LVOTO 3

Electrocardiographic Abnormalities

The 12-lead ECG is abnormal in 75-95% of HCM patients and serves as a sensitive—though non-specific—early marker 1, 2. This is critical because ECG changes often precede the development of overt left ventricular hypertrophy on imaging 5.

Common ECG Patterns

  • Left ventricular hypertrophy voltage criteria (present in 76% of cases) 4
  • Deep T-wave inversions in precordial leads: Particularly characteristic of apical HCM when associated with relative apical hypertrophy (apex:base wall thickness ratio >1, even with apical wall thickness <15 mm) 6
  • Pathological Q waves: Pseudo-infarction pattern, especially in inferior and lateral leads 2
  • ST-segment abnormalities
  • Wolff-Parkinson-White pattern: May suggest certain HCM phenocopies 2

Important caveat: ECG abnormalities do not correlate with the severity or pattern of hypertrophy on imaging 2.

Incidental Findings Leading to Diagnosis

Many asymptomatic adults are diagnosed incidentally through:

Screening Scenarios

  • Cardiac murmur detected during routine examination (23.7% of cases in one series) 4
  • Abnormal ECG during pre-participation sports screening or routine health assessment 7, 2
  • Family screening after HCM diagnosis in a relative 6

Ambulatory ECG Monitoring Findings

While not typically part of initial clinical examination, 24-hour Holter monitoring is recommended at initial assessment and may reveal 1, 2:

  • Non-sustained ventricular tachycardia (NSVT): Present in 25% of adults with HCM, rate 120-200 bpm
  • Paroxysmal supraventricular arrhythmias: Up to 38% of patients
  • These findings have prognostic implications for sudden cardiac death risk

Diagnostic Approach Algorithm

When HCM is suspected based on clinical signs:

  1. Obtain 12-lead ECG immediately (Class I recommendation) 2, 3

    • If abnormal → proceed to echocardiography
    • If normal → does not exclude HCM; proceed to imaging if clinical suspicion remains high
  2. Perform comprehensive echocardiography looking for:

    • Maximum LV wall thickness ≥15 mm (or ≥13 mm with family history/genetic variant) 6, 8, 9
    • Asymmetric septal hypertrophy (most common pattern)
    • Systolic anterior motion of mitral valve
    • Dynamic LVOTO (gradient ≥30 mm Hg diagnostic; ≥50 mm Hg hemodynamically significant) 1
  3. Perform provocative maneuvers during examination:

    • Valsalva maneuver
    • Standing from squatting position
    • These unmask latent LVOTO in up to 50% of patients with normal resting gradients 10, 3

Critical Diagnostic Pitfalls

Hypertension Confounding Diagnosis

Hypertension coexists in 25-33% of newly diagnosed HCM patients 6. Distinguishing features favoring HCM over hypertensive heart disease:

  • Mild hypertension with asymmetric and/or severe wall thickening (>18 mm) suggests HCM 6
  • Severe hypertension with mild symmetric hypertrophy favors hypertensive heart disease
  • Advanced diastolic dysfunction out of proportion to hypertension severity indicates possible HCM 6

Elderly Patients

Isolated basal septal hypertrophy (sigmoid septum) in elderly patients with hypertension presents a diagnostic conundrum—distinction between benign aging changes and pathologic HCM may not be clear 6.

Late-Onset Disease

HCM phenotype can develop well into adulthood and even advanced age (documented onset >40, >50, and >70 years) 5. This has critical implications: ECG repolarization abnormalities (particularly T-wave inversions) can predict future development of apical LV hypertrophy in adults, emphasizing the value of serial screening beyond adolescence in at-risk individuals 5.

Prognosis Context

Completely asymptomatic adult patients have significantly lower cardiac mortality (0.9% annual rate) compared to symptomatic patients (1.9%), with disproportionately low sudden death incidence (0.1% vs 1.4% annually) 11. However, approximately one-third of initially asymptomatic patients will develop symptoms during follow-up, though most remain free of important cardiac symptoms over an average 8-year period 11, 12.

References

Research

Onset of apical hypertrophic cardiomyopathy in adulthood.

The American journal of cardiology, 2011

Research

Prognosis of completely asymptomatic adult patients with hypertrophic cardiomyopathy.

Journal of the American College of Cardiology, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.